Clinical Trial Update: Genotypic Tropism Testing In Proviral Dna To Guide CCR5 Antagonist Treatment In Subjects With Undetectable HIV-1 Viremia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating genotypic tropism testing in proviral DNA to guide CCR5 antagonist therapy in people with undetectable HIV-1 viremia has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Conditions: HIV | Phase 4 | Status: COMPLETED